NJ State Employees Deferred Compensation Plan’s Xenon Pharmaceuticals XENE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-25,000
Closed -$1M 422
2025
Q3
$1M Hold
25,000
0.11% 186
2025
Q2
$783K Hold
25,000
0.09% 205
2025
Q1
$839K Hold
25,000
0.11% 186
2024
Q4
$980K Hold
25,000
0.12% 177
2024
Q3
$984K Hold
25,000
0.12% 180
2024
Q2
$975K Hold
25,000
0.12% 172
2024
Q1
$1.08M Hold
25,000
0.14% 165
2023
Q4
$1.15M Hold
25,000
0.16% 144
2023
Q3
$854K Hold
25,000
0.13% 173
2023
Q2
$963K Hold
25,000
0.14% 167
2023
Q1
$895K Hold
25,000
0.14% 176
2022
Q4
$986K Hold
25,000
0.16% 151
2022
Q3
$903K Hold
25,000
0.15% 154
2022
Q2
$761K Hold
25,000
0.12% 177
2022
Q1
$764K Hold
25,000
0.1% 203
2021
Q4
$781K Hold
25,000
0.1% 211
2021
Q3
$382K Hold
25,000
0.05% 347
2021
Q2
$466K Hold
25,000
0.06% 315
2021
Q1
$448K Hold
25,000
0.06% 323
2020
Q4
$385K Hold
25,000
0.06% 329
2020
Q3
$277K Hold
25,000
0.05% 343
2020
Q2
$314K Hold
25,000
0.06% 312
2020
Q1
$284K Hold
25,000
0.06% 297
2019
Q4
$328K Hold
25,000
0.06% 381
2019
Q3
$225K Hold
25,000
0.04% 457
2019
Q2
$247K Hold
25,000
0.04% 480
2019
Q1
$254K Hold
25,000
0.05% 471
2018
Q4
$158K Hold
25,000
0.03% 482
2018
Q3
$330K Sell
25,000
-25,000
-50% -$290K 0.06% 417
2018
Q2
$460K Buy
50,000
+30,000
+150% +$186K 0.08% 330
2018
Q1
$98K Hold
20,000
0.02% 465
2017
Q4
$57K Hold
20,000
0.01% 459
2017
Q3
$59K Hold
20,000
0.01% 454
2017
Q2
$63K Hold
20,000
0.01% 407
2017
Q1
$80K Hold
20,000
0.02% 382
2016
Q4
$154K Hold
20,000
0.03% 353
2016
Q3
$162K Hold
20,000
0.03% 346
2016
Q2
$118K Hold
20,000
0.03% 359
2016
Q1
$143K Hold
20,000
0.03% 359
2015
Q4
$161K Hold
20,000
0.03% 361
2015
Q3
$165K Hold
20,000
0.04% 360
2015
Q2
$231K Buy
+20,000
New +$276K 0.04% 346

Other funds holding XENE